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ABSTRACT
Objective To develop a model based on non-invasive
variables to predict the probability of intra-amniotic
inflammation in women with preterm labor and intact
membranes.
Methods Transvaginal ultrasonography and digital exam-
ination for the assessment of cervical length and cervical
dilatation were performed, and maternal blood was col-
lected for the determination of C-reactive protein and
white blood cell (WBC) count immediately after amnio-
centesis in 153 consecutive women with preterm labor.
Amniotic fluid obtained by amniocentesis was cultured for
aerobic and anaerobic bacteria and mycoplasmas, and the
WBC was determined. Intra-amniotic inflammation was
defined as an elevated amniotic fluid interleukin-6 concen-
tration (>2.6 ng/mL). Receiver–operating characteristics
(ROC) curves and logistic regression analysis were used
for statistical analysis.
Results The prevalence of a positive amniotic fluid culture
was 7.2% (11/153) and the prevalence of intra-amniotic
inflammation was 19.6% (30/153). The final logistic
regression model was based on non-invasive clinical
variables, including gestational age at assessment, cervical
length and maternal blood WBC count, which were
the best predictors of intra-amniotic inflammation. The
model was shown to have an adequate goodness of fit
(P = 0.754), and the area under the ROC curve was
0.724, indicating reasonably good discrimination.
Conclusion In women with preterm labor and intact
membranes, the risk for intra-amniotic inflammation can
be predicted non-invasively with a risk score based on
gestational age, cervical length and maternal blood WBC
count. Copyright  2010 ISUOG. Published by John
Wiley & Sons, Ltd.
INTRODUCTION
A growing body of evidence indicates that women in
preterm labor with intra-amniotic inflammation, but
not microbial invasion of the amniotic cavity, have
a similar outcome to those with microbial invasion
of the amniotic cavity1,2. Therefore, from a practical
point of view, an early and accurate detection of
intra-amniotic inflammation may be more important
than that of microbial invasion of the amniotic cavity
in the management of women with preterm labor.
The antenatal detection of intra-amniotic inflammation
requires laboratory studies of white blood cells (WBC)
and inflammatory markers in amniotic fluid (AF) obtained
by amniocentesis, such as AF cytokine determination1–4.
However, amniocentesis is an invasive method5, although
it is generally considered a relatively simple and safe
procedure when performed by an experienced physician.
Consequently, alternative approaches for the rapid and
non-invasive identification of intra-amniotic inflammation
are needed for women with preterm labor.
Transvaginal ultrasonography has been widely accepted
as a non-invasive and objective method for the evaluation
of cervical status in women with preterm labor6,7. Several
studies have shown a significant relationship between
a short cervix detected by transvaginal ultrasound,
microbial invasion of the amniotic cavity, and impending
delivery in women with preterm labor8–10, while
measurement of C-reactive protein or the WBC count
in maternal blood has been shown to be a clinically useful
biochemical non-invasive approach for discriminating
women in preterm labor who are at high risk for
microbial invasion of the amniotic cavity and failed
tocolysis11–13. However, to date, there has been a paucity
of data regarding non-invasive clinical and sonographic
parameters, individually or in combination, as a clinically
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useful method for identifying intra-amniotic inflammation
in women with preterm labor. This information is
clinically relevant, since it may decrease unnecessary
invasive intervention (e.g. amniocentesis) for women
in preterm labor and non-invasively identify patients
who may benefit from close surveillance and more
aggressive treatment, such as administration of antibiotics
or corticosteroid. The purpose of this study was to develop
a model based on non-invasive clinical parameters to
predict the probability of intra-amniotic inflammation in
women with preterm labor and intact membranes.
PATIENTS AND METHODS
The study population consisted of consecutive women
admitted to Seoul National University Bundang Hos-
pital between October 2005 and December 2009 with
the diagnosis of preterm labor and intact membranes
who met the following criteria: (1) singleton gestation;
(2) transabdominal amniocentesis performed for micro-
biological studies of amniotic cavity; (3) cervical length
measured at the time of amniocentesis; (4) maternal blood
drawn immediately after amniocentesis for the determina-
tion of WBC and C-reactive protein concentrations; (5) a
live fetus with a gestational age between 21 and 35 weeks;
(6) cervical dilatation of ≤ 3 cm by digital examination;
(7) no history of prior or subsequent cervical cerclage;
and (8) absence of a major fetal congenital anomaly. The
non-invasive clinical parameters that were collected at
the time of enrollment included demographic variables
(maternal age, parity and previous preterm delivery),
gestational age at assessment, C-reactive protein con-
centration, maternal serum WBC count, cervical length
assessed by transvaginal ultrasonography and cervical
dilatation by digital examination. Clinical and labora-
tory data were collected prospectively. Amniocentesis for
retrieval of AF and measurement of cervical length are
recommended to all patients who are admitted with the
diagnosis of preterm labor and intact membranes at our
institution. The study was approved by the Institutional
Review Board of the Seoul National University Bundang
Hospital, and informed consent was obtained from all
study subjects.
Patients were hydrated and if uterine contractions per-
sisted, they were started on a regimen of intravenous
tocolysis with ritodrine or magnesium sulfate after amnio-
centesis. Corticosteroids were administered between 24
and 34 weeks’ gestation. Preterm labor was defined as the
presence of regular uterine contractions with a frequency
of at least two every 10 min and cervical change before 37
completed weeks of gestation that required hospitaliza-
tion. Intra-amniotic infection was defined as a positive AF
culture for microorganisms. Intra-amniotic inflammation
was diagnosed by an amniotic fluid interleukin-6 (IL-6)
concentration > 2.6 ng/mL, as previously reported1.
Transabdominal amniocentesis was used to obtain
AF under ultrasonographic guidance. Microbiological
evaluation included cultures for aerobic and anaerobic
bacteria and mycoplasmas (Ureaplasma urealyticum and
Mycoplasma hominis), according to methods previously
described14. An aliquot of AF was transferred to the
hematology laboratory and examined in a hemocytometer
chamber for the presence of WBCs. The absolute WBC
count was calculated by multiplying the area examined
by a factor of 10 per area and was expressed as
the number of cells per cubic mm. AF that was not
required for clinical assessment was centrifuged, and the
supernatant liquid was aliquoted and stored at −70◦C
until assayed. Samples were not subjected to freeze–thaw
cycles before being assayed. IL-6 concentrations were
measured by an enzyme-linked immunosorbent assay
(human IL-6 DuoSet Kit; R&D Systems, Minneapolis,
MN, USA). The range of the IL-6 standard curve is
7.8–600 pg/mL. The assay was carried out by strictly
following the instructions provided by the manufacturer
and all samples were measured in duplicate at the same
time. The calculated intra- and interassay coefficients of
variation were < 10%. The maternal blood WBC count
was determined using an automated hemocytometer (XE-
2100; Sysmex, Tokyo, Japan). The C-reactive protein
concentration was measured with a latex-enhanced
turbidimetric immunoassay (Denka Seiken, Tokyo, Japan)
using Toshiba 200FR (Toshiba, Tokyo, Japan).
Transvaginal ultrasonographic assessment of cervical
length was performed by trained physicians immediately
after amniocentesis using an Envisor ultrasound machine
with a 6.0-MHz transducer (Philips Medical Systems,
Eindhoven, The Netherlands). The method used for
measurements of cervical length has been previously
described15. Three measurements were performed and
the shortest distance was taken as the cervical length.
Univariate analysis was conducted with the Student’s
t-test, Mann–Whitney U-test, or chi-square test. The
Shapiro–Wilk and Kolmogorov–Smirnov tests were
used to test for normal distribution of data and
logistic regression analysis was used to investigate
the regression relationship between various predictors
and intra-amniotic inflammation. To develop a non-
invasive model for the prediction of intra-amniotic
inflammation, non-invasive clinical parameters that
presented a significant correlation or a tendency towards
an association with intra-amniotic inflammation in
univariate analysis (P < 0.25) were subjected to stepwise
backward logistic regression analysis. The linearity
of continuous variables was assessed using fractional
polynomials16. The goodness-of-fit of a logistic regression
model was assessed by the Hosmer–Lemeshow test.
Factors included in the final logistic regression model
were used to set up the scores for the probability of
intra-amniotic inflammation. Using the constant of the
logistic regression analysis and the beta-coefficients for
the identified predictive factors in the final risk scoring
model, the individual probability of having an intra-
amniotic inflammation for each woman in preterm labor
was calculated. Discriminatory ability of this model
was measured by the area under the receiver–operating
characteristics (ROC) curve17. The model’s value that
maximized the sum of the sensitivity and specificity
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and was able to minimize the misclassification rate was
considered the best cut-off. A univariate Z-score test was
used to estimate the statistical significance of the difference
in the area under the curve between the AF-WBC count
and the final risk scoring model18. All reported P-values
are two-sided, and P < 0.05 was considered statistically
significant. SPSS 12.0.1 for Windows (SPSS Inc., Chicago,
IL, USA) was used for statistical analysis.
RESULTS
During the study period, 165 consecutive women with
preterm labor were recruited. Of the 165 women, AF
was not available in seven women for IL-6 determination
(six women with a negative AF culture and one woman
with a positive AF culture) and five had a history of
cervical cerclage placement during the index pregnancy.
These women were excluded from the study, leaving 153
women suitable for evaluation. The gestational age of the
women included in our study at the time of amniocentesis
ranged from 21 + 2 to 35 + 0 weeks’ gestation. The
overall rate of intra-amniotic inflammation was 19.6%
(30/153) and the prevalence of a positive AF culture
was 7.2% (11/153). The microorganisms isolated from
the amniotic cavity included Ureaplasma urealyticum
(n = 10) and Mycoplasma hominis (n = 9), with both
found in eight cases. Intra-amniotic inflammation was
present in all cases with a positive AF culture and
intra-amniotic inflammation with a negative AF culture
occurred in 13.4% of samples (19/142).
Table 1 shows the demographic and clinical character-
istics of the women according to the presence or absence of
intra-amniotic inflammation. Women with intra-amniotic
inflammation had a significantly lower mean gestational
age at assessment and at delivery, a lower mean cervical
length, and a higher mean maternal serum C-reactive pro-
tein concentration and WBC count than did those without
intra-amniotic inflammation. However, there were no
significant differences in the mean maternal age, nullipar-
ity, prevalence of previous spontaneous preterm delivery
and mean cervical dilatation between the two groups.
The mean AF-WBC count and the proportion of posi-
tive AF cultures were significantly higher in women with
intra-amniotic inflammation than in those without intra-
amniotic inflammation.
To identify the final non-invasive predictors of
intra-amniotic inflammation, we performed multivariate
analysis using a stepwise logistic regression model.
After the exclusion of variables (i.e. AF-WBC count
and AF culture results) using invasive amniocentesis,
four variables with a significant correlation or a
tendency towards an association with intra-amniotic
inflammation based on univariate analysis (P < 0.25)
were entered into the multivariate model (gestational
age at assessment, sonographic cervical length, maternal
serum C-reactive protein and maternal blood WBC
count). The final variables retained in the non-invasive
model were gestational age at assessment, cervical
length and maternal blood WBC count (Table 2). There
were no statistically significant interactions between the
predictors selected in the multivariate model. Because
fractional polynomial analysis yielded significant linear
functions for these three predictors, we used these as
continuous variables. The formula that was generated
to predict intra-amniotic inflammation is: Y = loge(Z)
= 3.375 − (0.180 × gestational age) + (0.130 ×
WBC count) − (0.399 × cervical length), where
gestational age is given in weeks, WBC count in
thousands of cells per mm3 and cervical length in cm.
Z = ey and risk (%) = (Z/(1 + Z)) × 100.
The discriminatory ability of this model was 0.724
(95% confidence interval (CI), 0.622–0.826), suggesting
a reasonably good discrimination between women
with and without intra-amniotic inflammation. The
Hosmer–Lemeshow test showed an adequate fit of the
model studied (P = 0.754).
The sensitivity, specificity, positive predictive value,
negative predictive value and likelihood ratios of
the different cut-offs of probability for intra-amniotic
inflammation using the formula with the three non-
invasive parameters are shown in Table 3. A risk score
of 20% for a given woman in preterm labor was
Table 1 Demographic and clinical characteristics of the study population according to presence or absence of intra-amniotic inflammation
Intra-amniotic inflammation
Characteristic Absent (n = 123) Present (n = 30) P
Maternal age (years) 31.0 ± 4.1 31.3 ± 4.5 0.753
Nulliparous 77 (62.6) 17 (56.7) 0.676
Previous spontaneous preterm birth (at < 37 weeks) 10 (8.1) 2 (6.7) 1.0
Gestational age at assessment (weeks) 30.7 ± 3.2 28.7 ± 3.6 0.004
Gestational age at delivery (weeks) 36.6 ± 3.1 31.3 ± 4.9 <0.0001
Cervical length by ultrasound (mm) 26.8 ± 12.0 20.8 ± 11.0 0.014
Cervical dilatation by digital examination (mm) 7.1 ± 9 6.7 ± 10 0.792
White blood cell count (cells/mm3) 10 755 ± 3258 12 474 ± 3135 0.010
C-reactive protein (mg/dL) 0.9 ± 1.5 1.8 ± 1.9 0.013
Amniotic fluid white blood cell count (cells/mm3) 8.9 ± 31.0 916.1 ± 1360.9 0.001
Positive amniotic fluid culture 0 11 (36.7) <0.0001
Values are given as mean ± SD or n (%). Intra-amniotic inflammation defined as interleukin-6 level > 2.6 ng/mL.
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Table 2 Regression coefficients, odds ratios, and 95% CIs of the final model to predict probability of having intra-amniotic inflammation
Predictor Beta-coefficient SE Odds ratio (95% CI) P
Gestational age at assessment (weeks) −0.180 0.063 0.836 (0.739–0.945) 0.004
While blood cell count (thousand/mm3) 0.130 0.063 1.139 (1.007–1.289) 0.038
Cervical length (cm) −0.399 0.186 0.671 (0.466–0.965) 0.032
Constant 3.375 2.063 29.230 0.102
Table 3 Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values and likelihood ratios (LR) of the different cut-offs of
probability for intra-amniotic inflammation predicted from the final model using three non-invasive parameters
Predicted
probability
Screened
positive (n (%)) Sensitivity (%) Specificity (%) PPV (%) NPV (%) LR+ LR−
≥ 0.1 103 (67.3) 83.3 36.6 24.3 90.0 1.31 0.46
≥ 0.2 55 (35.9) 66.7 71.5 36.4 89.8 2.34 0.47
≥ 0.3 36 (23.5) 46.7 82.1 38.9 86.3 2.61 0.65
≥ 0.4 13 (8.5) 20.0 94.3 46.2 82.9 3.51 0.85
≥ 0.5 7 (4.6) 16.7 98.4 71.4 82.9 10.44 0.85
identified as being the optimal threshold for sensitivity
and specificity, and a high proportion of women classified
correctly. Thirty-six percent of the women had an
estimated probability for intra-amniotic inflammation
≥ 0.2, and 36% of these women were diagnosed
with intra-amniotic inflammation. Moreover, this group
included 67% of all women who had intra-amniotic
inflammation.
Figure 1 displays ROC curves comparing the predic-
tions provided by the AF-WBC count and the non-invasive
model for the risk of intra-amniotic inflammation. The
area under the ROC curve for the AF-WBC count was
slightly larger than that for the non-invasive model; how-
ever, these results were determined not to be statistically
significant for a 95% confidence level (0.826 (95% CI,
0.724–0.928) vs. 0.724 (95% CI, 0.622–0.826), respec-
tively; P = 0.165). Nonetheless, in comparison with each
of the three variables retained in the non-invasive model,
ROC curve analysis demonstrated that an AF-WBC count
was superior to any other parameter in the prediction
of intra-amniotic inflammation (gestational age at assess-
ment, cervical length and maternal blood WBC count;
P < 0.05 for each). In comparison, the area under the
ROC curve for the non-invasive model was significantly
higher than that for cervical length (P = 0.033) but
not significantly higher than that for maternal WBC
count (P = 0.342) and gestational age at assessment
(P = 0.259).
DISCUSSION
The results of our study clearly demonstrate that the
risk of intra-amniotic inflammation among women with
preterm labor and intact membranes can be predicted
by three non-invasive clinical parameters (gestational
age at assessment, cervical length and maternal WBC
count). Moreover, the model obtained by combining these
parameters has reasonably good discriminatory power
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Figure 1 Receiver–operating characteristics (ROC) curves
comparing the predictions provided by the amniotic fluid (AF)
white blood cell (WBC) count ( ) and the non-invasive model
( ) for the risk of intra-amniotic inflammation. There was no
statistically significant difference between the areas under the ROC
curves (AUC) of AF-WBC count and the non-invasive model (AUC
for AF-WBC, 0.826; SE 0.052, P < 0.0001; AUC for non-invasive
model, 0.724; SE 0.052, P < 0.0001; P = 0.165 for difference
between the two ROC curves).
and may be useful for selecting the subset of women with
preterm labor and intact membranes requiring invasive
amniocentesis.
The novelty of our approach for identifying intra-
amniotic inflammation is the use of combinations of
non-invasive parameters, by means of which we can
obtain a higher discrimination power than is possible
with any single parameter. The area under the curve from
ROC-curve analysis ranged from 0.638 to 0.676 for each
Copyright  2010 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2011; 37: 82–87.
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of the three parameters individually; the combination of
these parameters improved the diagnostic accuracy to an
area under the curve of 0.724, although the improvement
reached statistical significance only in the comparison of
cervical length. These findings support the notion that a
single predictive model that combines clinical, laboratory
and ultrasound parameters is useful for providing a
clinically meaningful non-invasive prediction of intra-
amniotic inflammation in women with preterm labor.
From a practical point of view, we propose that
screening for intra-amniotic inflammation should begin
with this non-invasive model and that those women
shown to be in the high-risk group could then be
considered for amniocentesis to obtain a quantitative
AF-IL-6 level, which is a more accurate prediction of
intra-amniotic inflammation. Based on our suggested risk-
score threshold (≥ 0.2), the use of this model would lead
to safely avoiding amniocentesis in 89% of women with
clinical and laboratory data indicating the absence of
an intra-amniotic inflammation and reduce the number
of amniocenteses by approximately two-thirds (64%).
However, this risk-score threshold is not fixed, and
can vary according to the patient’s or obstetrician’s
tolerance of risk. Some may prefer to select a lower
risk threshold to ensure that women truly at high risk
for intra-amniotic inflammation are not missed, whereas
others may prefer to choose a higher threshold value to
minimize the false-positive error rate. For example, as
shown in Table 3, a lower score threshold (e.g. ≥ 0.1)
would have the greatest sensitivity (83.3%) and negative
predictive value (90%), which would make this model
an excellent tool for the identification of women at
low risk of intra-amniotic inflammation and in whom
amniocentesis may be avoided, while reducing the number
of amniocenteses by 33%. By contrast, a higher score
threshold (e.g. ≥ 0.5) would minimize the false-positive
rate (1.6%), but increase the likelihood of a false-negative
result (83.3%) and the corresponding risk region would
comprise only 4.6% of the population. Furthermore, this
cut-off threshold has a limited positive predictive value of
71.4%, which is unacceptably low for a diagnostic test.
Only two published studies have reported a significant
association between intra-amniotic inflammation and a
short cervix in women with preterm labor and intact
membranes19,20. In the current study this association
was confirmed by means of univariate analysis, and
remained significant even after adjustment for gestational
age at the time of examination. Similar observations
have been reported in the setting of intra-amniotic
infection in women with preterm labor8–10. The
proposed mechanism for these observations is that
microorganisms that gain access to the intrauterine
cavity stimulate the production of pro-inflammatory
cytokines and inflammatory mediators, and cause cervical
shortening secondarily. Alternatively, it could be that an
already shortened cervix predisposes women to ascending
bacterial infections from the vagina and cervix, and then
induces activation of cytokines.
Our observation that an elevated WBC count or C-
reactive protein concentration in the maternal blood is
associated with intra-amniotic inflammation in women
with preterm labor was not unexpected because several
studies have demonstrated that an AF-IL-6 determination
is an excellent predictor of histologic chorioamnionitis
reflecting a maternal inflammatory response14,21. Indeed,
an inflammatory process during the course of an
ascending intrauterine infection is generally regarded
as a continuum of maternal and fetal inflammatory
responses. During the early stage, localized inflammation
confined to the chorion-decidua, which represents the
maternal host response, releases various cytokines in
the maternal circulation, and these, in turn, lead to
leukocytosis and C-reactive protein production22,23. On
the other hand, the later stage involves microbial invasion
of the amniotic cavity through the amnion, where
microorganisms can also stimulate the production of
inflammatory mediators by resident macrophages and
other host cells, and eventually leads to a fetal systemic
inflammatory response23. Therefore, given that the intra-
amniotic inflammatory response is a part of the advanced
stage of an ascending intrauterine infection and is
solely of fetal origin23,24, our observations strongly
suggest that many women with a marked rise in
inflammatory markers in peripheral blood may already
have a fetal systemic inflammatory response mediated
by cytokines. Further studies are needed to focus on
whether maternal blood tests, such as the WBC count
and C-reactive protein level reflecting the maternal
inflammatory response, are of value in predicting a
fetal systemic inflammatory response in women with
preterm labor. Our finding that the earlier the gestational
age at which the woman presented, the more likely
that an intra-amniotic inflammation was present, is in
agreement with previous studies1,20. In addition, other
investigators have also reported an inverse relationship
between gestational age at presentation and microbial
colonization of the AF or chorioamnion in women with
preterm labor4,25.
The present study had several limitations. First, our
cohort consisted of women from one hospital; therefore,
our non-invasive model may not be generalizable to other
populations of women and consequently a prospective
validation in another study population is needed to
establish the actual validity. Second, the model did
not include some previously reported important non-
invasive predictors, such as determination of cervical
fluid cytokines10,26,27. Third, in the present study the
prevalence of a positive AF culture was 7.2% and the
prevalence of intra-amniotic inflammation was 19.6%,
values that are lower than those reported by other
investigators (range for a positive AF culture, 8.7–33.8%;
range for intra-amniotic inflammation, 30–39%)5,7,28.
However, the prevalence of intra-amniotic inflammation
may be affected by how it is defined, the gestational
age at which the amniocentesis was performed and the
threshold required to perform an amniocentesis in women
with preterm labor at different centers.
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In conclusion, we have demonstrated that a model
based on easily obtainable, non-invasive parameters in
the setting of preterm labor with intact membranes can
identify women at high risk for intra-amniotic inflamma-
tion. This model can serve as an important tool for
predicting individual intra-amniotic inflammation risk
probabilities for obstetricians and may enhance patient
care by targeting aggressive therapy, including amnio-
centesis and antibiotic/anti-inflammatory treatment, to
high-risk groups.
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